![7 Questions and Answers Concerning Newly Approved COVID-19 Boosters | Moultrie County Health Department 7 Questions and Answers Concerning Newly Approved COVID-19 Boosters | Moultrie County Health Department](https://www.moultriehealth.org/wp-content/uploads/close-up-of-hands-holding-covid-vaccine-vial-web.jpg)
7 Questions and Answers Concerning Newly Approved COVID-19 Boosters | Moultrie County Health Department
![Bivalent booster recipients show slightly higher protection against infection and significantly higher protection against death than monovalent booster recipients Bivalent booster recipients show slightly higher protection against infection and significantly higher protection against death than monovalent booster recipients](https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_738649_16762847469299512.jpg)
Bivalent booster recipients show slightly higher protection against infection and significantly higher protection against death than monovalent booster recipients
![Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog](https://i0.wp.com/covidblog.oregon.gov/wp-content/uploads/2022/09/bivalent.jpg?fit=4431%2C2954&ssl=1)
Updated COVID-19 booster targets subvariants responsible for 98% of cases today : Oregon Health News Blog
![Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ... Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e1_BivalentVECurrentSublineages_IMAGE_25Jan2023_1200x675-medium.jpg?_=95835)
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing ...
![Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health](https://publichealth.jhu.edu/sites/default/files/styles/article_feature/public/2023-02/bivalent-vaccine-g1422104879.jpg?h=f7026c63&itok=62rHr_a_)
Common Questions About Bivalent COVID-19 Boosters | Johns Hopkins | Bloomberg School of Public Health
![Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 | MMWR Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 | MMWR](https://www.cdc.gov/mmwr/volumes/72/wr/social-media/mm7205e3_CurrentVariants_Immunocompromised_IMAGE_27Jan2023_1200x675_1-medium.jpg?_=59980)
Information for Persons Who Are Immunocompromised Regarding Prevention and Treatment of SARS-CoV-2 Infection in the Context of Currently Circulating Omicron Sublineages — United States, January 2023 | MMWR
![Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents — United States, November 20, 2022–January 8, 2023 | MMWR Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents — United States, November 20, 2022–January 8, 2023 | MMWR](https://www.cdc.gov/mmwr/volumes/72/wr/figures/mm7225a4-F-large.gif?_=65224)
Effectiveness of Up-to-Date COVID-19 Vaccination in Preventing SARS-CoV-2 Infection Among Nursing Home Residents — United States, November 20, 2022–January 8, 2023 | MMWR
![Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases](https://www.thelancet.com/cms/asset/683be916-2b6a-4719-b001-feea7e4130e9/gr1.jpg)
Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study - The Lancet Infectious Diseases
![Even bivalent updated COVID-19 boosters struggle to prevent omicron subvariant transmission – an immunologist discusses why new approaches are necessary Even bivalent updated COVID-19 boosters struggle to prevent omicron subvariant transmission – an immunologist discusses why new approaches are necessary](https://images.theconversation.com/files/506017/original/file-20230124-17-uye0hb.jpg?ixlib=rb-1.1.0&rect=41%2C30%2C6837%2C3413&q=45&auto=format&w=1356&h=668&fit=crop)
Even bivalent updated COVID-19 boosters struggle to prevent omicron subvariant transmission – an immunologist discusses why new approaches are necessary
![Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation - The Lancet Infectious Diseases Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation - The Lancet Infectious Diseases](https://www.thelancet.com/cms/attachment/f8841dac-dc6a-4040-8138-e6c2a5eff780/gr1a_lrg.jpg)
Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation - The Lancet Infectious Diseases
![Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR](https://www.cdc.gov/mmwr/volumes/71/wr/social-media/mm7148e1-BivalentBooster_IMAGE_22NOV2022_1200x675.jpg?_=65732)
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 | MMWR
![Updated COVID-19 booster targets subvariants responsible for 98% of cases today | Malheur County Health Department Updated COVID-19 booster targets subvariants responsible for 98% of cases today | Malheur County Health Department](https://i0.wp.com/covidblog.oregon.gov/wp-content/uploads/2022/09/Bivalent_2.jpg?resize=526%2C526&ssl=1)